AAAAAA
Results: 1-25/62
Authors:
GERSHLICK AH
BARON J
Citation: Ah. Gershlick et J. Baron, DEALING WITH IN-STENT RESTENOSIS, HEART, 79(4), 1998, pp. 319-323
Authors:
GERSHLICK AH
MORE RS
Citation: Ah. Gershlick et Rs. More, RECENT ADVANCES - TREATMENT OF MYOCARDIAL-INFARCTION, BMJ. British medical journal, 316(7127), 1998, pp. 280-284
Authors:
BARON JH
MOISEEVA EP
AZRIN MA
EZEKOWITZ MD
DEBONO DP
GERSHLICK AH
Citation: Jh. Baron et al., C7E3 FAB (ABCIXIMAB) INHIBITS THE MIGRATION OF VASCULAR SMOOTH-MUSCLECELLS VIA THE ALPHA(V)BETA(3) INTEGRIN - A POSSIBLE EXPLANATION FOR PREVENTION OF RESTENOSIS, Circulation, 98(17), 1998, pp. 4243-4243
Authors:
BARON JH
AGGARWAL RK
AZRIN MA
EZEKOWITZ MD
DEBONO DP
GERSHLICK AH
Citation: Jh. Baron et al., DEVELOPMENT OF C7E3 FAB (ABCIXIMAB) ELUTING STENTS FOR LOCAL-DRUG DELIVERY - EFFECT OF STERILIZATION AND STORAGE, Circulation, 98(17), 1998, pp. 4487-4487
Authors:
FOO RSY
HOGREFE K
BARON JH
AZRIN MA
EZEKOWITZ MD
DEBONO DP
GERSHLICK AH
Citation: Rsy. Foo et al., ACTIVATED PROTEIN-C ADSORBED ON A STENT REDUCES ITS THROMBOGENICITY, Circulation, 98(17), 1998, pp. 4488-4488
Authors:
GERSHLICK AH
Citation: Ah. Gershlick, ANTIPLATELET THERAPY FOLLOWING STENT DEPLOYMENT, HEART, 78, 1997, pp. 24-26
Authors:
AGGARWAL RK
IRELAND DC
EZEKOWITZ MD
DEBONO DP
GERSHLICK AH
Citation: Rk. Aggarwal et al., CYCLIC FLOW VARIATION FREQUENCY PREDICTS ARTERIAL-OCCLUSION IN A RABBIT ILIAC ARTERY MODEL OF STENT THROMBOSIS, Journal of the American College of Cardiology, 29(2), 1997, pp. 7346-7346
Authors:
AGGARWAL RK
IRELAND DC
AZRIN MA
DEBONO DP
GERSHLICK AH
Citation: Rk. Aggarwal et al., REDUCTION IN THROMBOGENICITY OF CELLULOSE POLYMER-COATED STENTS BY IMMOBILIZATION OF PLATELET-TARGETED UROKINASE, Journal of the American College of Cardiology, 29(2), 1997, pp. 7714-7714
Authors:
GERSHLICK AH
Citation: Ah. Gershlick, TREATING THE NON-ELECTRICAL RISKS OF ATRIAL-FIBRILLATION, European heart journal, 18, 1997, pp. 19-26
Authors:
BARON JH
DEBONO DP
AZRIN MA
EZEKOWITZ MD
GERSHLICK AH
Citation: Jh. Baron et al., ADSORPTION AND ELUTION OF C7E3FAB FROM POLYMER-COATED STENTS IN-VITRO- LOCAL-DELIVERY OF AN ANTITHROMBOTIC AGENT THAT ALSO MAY INHIBIT RESTENOSIS, Circulation, 96(8), 1997, pp. 2254-2254
Authors:
BARON JH
EZEKOWITZ M
AZRIN M
DEBONO DP
GERSHLICK AH
Citation: Jh. Baron et al., POLYMER-COATED STENT WIRES ELUTING C7E3 FAB INHIBIT PLATELET-AGGREGATION IN-VITRO, The American journal of cardiology, 80, 1997, pp. 30-30
Authors:
KELLY SJ
GOODYER PD
FOTHERGILL JC
JONES NB
DEBONO DP
GERSHLICK AH
Citation: Sj. Kelly et al., A FLUORESCENCE METHOD FOR DETECTING LOCALLY DELIVERED DRUGS IN-VIVO, The American journal of cardiology, 80, 1997, pp. 67-67
Authors:
BARON JH
EZEKOWITZ M
AZRIN M
DEBONA DP
GERSHLICK AH
Citation: Jh. Baron et al., C7E3FAB INHIBITS ADHESION OF SMOOTH-MUSCLE CELLS TO VITRONECTIN AND OSTEOPONTIN - A POSSIBLE WAY OF INHIBITING IN-STENT RESTENOSIS, The American journal of cardiology, 80, 1997, pp. 69-69
Authors:
BARON JH
AGGARWAL R
EZEKOWITZ M
AZRIN M
DEBONO DP
GERSHLICK AH
Citation: Jh. Baron et al., ADSORPTION AND ELUTION OF C7E3FAB FROM POLYMER-COATED STENT IN-VITRO - LOCAL-DELIVERY OF AN ANTITHROMBOTIC AGENT THAT ALSO MAY INHIBIT RESTENOSIS, The American journal of cardiology, 80, 1997, pp. 125-125
Authors:
MARTIN WA
AGGARWAL R
RUTHERFORD C
FERNS GA
GERSHLICK AH
Citation: Wa. Martin et al., EFFICIENCY OF LOCAL-DELIVERY OF ANTIPLATELET DERIVED GROWTH FACTOR-BBANTIBODY IN AN EXPERIMENTAL-MODEL OF BALLOON ANGIOPLASTY, The American journal of cardiology, 80, 1997, pp. 230-230
Authors:
AGGARWAL RK
IRELAND DC
DEBONO DP
GERSHLICK AH
Citation: Rk. Aggarwal et al., ANTITHROMBOTIC POTENTIAL OF POLYMER-COATED STENTS ELUTING PLATELET GLYCOPROTEIN IIB IIA ANTIBODY/, HEART, 75(5), 1996, pp. 175-175
Authors:
AGGARWAL RK
IRELAND DC
DEBONO DP
GERSHLICK AH
Citation: Rk. Aggarwal et al., IN-VITRO PREPARATION, CHARACTERIZATION AND ANTITHROMBOGENICITY OF PLATELET-TARGETED UROKINASE IMMOBILIZED TO POLYMER-COATED STENT WIRE, HEART, 75(5), 1996, pp. 247-247
Authors:
DEBONO D
GERSHLICK AH
SAMANI NJ
GARRATT CJ
Citation: D. Debono et al., NEW TRAINING GUIDELINES - WHAT ARE THE IMPLICATIONS FOR CARDIOLOGICALRESEARCH, HEART, 75(2), 1996, pp. 118-120
Authors:
GERSHLICK AH
Citation: Ah. Gershlick, MAGNESIUM AND ACUTE MYOCARDIAL-INFARCTION - MISUNDERSTOOD ION OR IRRELEVANT MOLECULE, European heart journal, 17(5), 1996, pp. 651-653
Authors:
GERSHLICK AH
AGGARWAL RK
Citation: Ah. Gershlick et Rk. Aggarwal, STENT THROMBOSIS REVISITED, European heart journal, 17(11), 1996, pp. 1623-1628
Authors:
MORE RS
BRACK MJ
GERSHLICK AH
Citation: Rs. More et al., ANGIOPLASTY BALLOON COMPLIANCE - CAN IN-VIVO SIZE BE PREDICTED FROM IN-VITRO PRESSURE PROFILE MEASUREMENTS, Clinical cardiology, 19(5), 1996, pp. 393-397
Authors:
SAMANI NJ
MARTIN DS
BRACK M
CULLEN J
WALLIS R
LODWICK D
CHAUHAN A
HARLEY A
THOMPSON JR
GERSHLICK AH
DEBONO DP
Citation: Nj. Samani et al., APOLIPOPROTEIN-E POLYMORPHISM DOES NOT PREDICT RISK OF RESTENOSIS AFTER CORONARY ANGIOPLASTY, Atherosclerosis, 125(2), 1996, pp. 209-216
Authors:
AGGARWAL RK
MARTIN WA
AZRIN MA
EZEKOWITZ MD
DEBONO DP
GERSHLICK AH
Citation: Rk. Aggarwal et al., EFFECTS OF PLATELET GPIIB IIIA ANTIBODY AND ANTIBODY-UROKINASE CONJUGATE ADSORBED TO STENTS ON PLATELET DEPOSITION AND NEOINTIMA FORMATION/, Circulation, 94(8), 1996, pp. 1510-1510
Authors:
AGGARWAL RK
IRELAND DC
AZRIN MA
EZEKOWITZ MD
DEBONO DP
GERSHLICK AH
Citation: Rk. Aggarwal et al., ANTITHROMBOTIC POTENTIAL OF POLYMER-COATED STENTS ELUTING PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTIBODY/, Circulation, 94(12), 1996, pp. 3311-3317
Authors:
BRACK MJ
RAY S
CHAUHAN A
FOX J
HUBNER PJB
SCHOFIELD P
HARLEY A
GERSHLICK AH
Citation: Mj. Brack et al., THE SUBCUTANEOUS HEPARIN AND ANGIOPLASTY RESTENOSIS PREVENTION (SHARP) TRIAL - RESULTS OF A MULTICENTER RANDOMIZED TRIAL INVESTIGATING THE EFFECTS OF HIGH-DOSE UNFRACTIONATED HEPARIN ON ANGIOGRAPHIC RESTENOSISAND CLINICAL OUTCOME, Journal of the American College of Cardiology, 26(4), 1995, pp. 947-954